See what is BPC-157
Depending on who you ask, it's either the future of regenerative medicine or the latest example of science being outrun by social media
On December 22nd, the Food and Drug Administration (FDA) approved Novo Nordisks oral semaglutide tablet, a 25 mg dose of the same active ingredient found in injectable Wegovy and Ozempic
Vitamin B12 aids in the growth of healthy blood cells, nerve cells, and bodily proteins
A randomized, placebo-controlled, double-blind, crossover trial was conducted in 42 patients with type 2 diabetes
Whitehouse F, Kruger DF, Fineman M et al (2002) A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes